Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Epizyme Beats Out the Market With FDA Approval
Epizyme Beats Out the Market With FDA Approval
Epizyme Beats Out the Market With FDA Approval
Submitted by
admin
on August 24, 2015 - 5:00pm
Source:
Yahoo/24-7 Wall St
News Tags:
FDA
Epizyme
tazemetostat
INI1-negative tumors
synovial sarcoma
Headline:
Epizyme Beats Out the Market With FDA Approval
Do Not Allow Advertisers to Use My Personal information
